These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1032 related items for PubMed ID: 20679547

  • 1. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 2. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S.
    Clin Exp Pharmacol Physiol; 2009 Mar 17; 36(3):262-6. PubMed ID: 18785976
    [Abstract] [Full Text] [Related]

  • 3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ, Shang QH, Jin HY, Song B, Oudit GY, Lu L, Zhou T, Xu YL, Gao PJ, Zhu DL, Penninger JM, Zhong JC.
    J Transl Med; 2013 Sep 25; 11():229. PubMed ID: 24067190
    [Abstract] [Full Text] [Related]

  • 4. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J, Guo D, Chen CB, Wang W, Schuster M, Loibner H, Penninger JM, Scholey JW, Kassiri Z, Oudit GY.
    Hypertension; 2011 Feb 25; 57(2):314-22. PubMed ID: 21189404
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats.
    Lo J, Patel VB, Wang Z, Levasseur J, Kaufman S, Penninger JM, Oudit GY.
    Exp Physiol; 2013 Jan 25; 98(1):109-22. PubMed ID: 22750422
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
    Patel VB, Takawale A, Ramprasath T, Das SK, Basu R, Grant MB, Hall DA, Kassiri Z, Oudit GY.
    J Mol Med (Berl); 2015 Sep 25; 93(9):1003-13. PubMed ID: 25874965
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Feb 25; 25(2):365-71. PubMed ID: 15576638
    [Abstract] [Full Text] [Related]

  • 8. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY, Chen LJ, Zhang ZZ, Xu YL, Song B, Xu R, Oudit GY, Gao PJ, Zhu DL, Zhong JC.
    J Transl Med; 2015 Aug 06; 13():255. PubMed ID: 26245758
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, Ebihara A, Suematsu Y, Kangawa K, Hirata Y, Nagai R.
    Circulation; 2004 Apr 13; 109(14):1789-94. PubMed ID: 14967720
    [Abstract] [Full Text] [Related]

  • 10. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T.
    Circ Res; 2008 Jan 04; 102(1):68-76. PubMed ID: 17967781
    [Abstract] [Full Text] [Related]

  • 11. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB, Bodiga S, Fan D, Das SK, Wang Z, Wang W, Basu R, Zhong J, Kassiri Z, Oudit GY.
    Hypertension; 2012 Jun 04; 59(6):1195-203. PubMed ID: 22508831
    [Abstract] [Full Text] [Related]

  • 12. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.
    Circ Res; 2008 Mar 28; 102(6):720-8. PubMed ID: 18258859
    [Abstract] [Full Text] [Related]

  • 13. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D, Takawale A, Basu R, Patel V, Lee J, Kandalam V, Wang X, Oudit GY, Kassiri Z.
    Cardiovasc Res; 2014 Jul 15; 103(2):268-80. PubMed ID: 24692173
    [Abstract] [Full Text] [Related]

  • 14. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G, Li X, Hein DW, Xiang X, Marshall JP, Prabhu SD, Cai L.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):655-66. PubMed ID: 18702970
    [Abstract] [Full Text] [Related]

  • 15. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY.
    Circ Heart Fail; 2009 Sep 19; 2(5):446-55. PubMed ID: 19808375
    [Abstract] [Full Text] [Related]

  • 16. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
    Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M.
    J Hypertens; 2011 Nov 19; 29(11):2236-45. PubMed ID: 21946695
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
    Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T.
    Arterioscler Thromb Vasc Biol; 2008 May 19; 28(5):863-70. PubMed ID: 18309113
    [Abstract] [Full Text] [Related]

  • 18. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM, Kassiri Z, Oudit GY.
    Cardiovasc Res; 2011 Jul 01; 91(1):151-61. PubMed ID: 21285291
    [Abstract] [Full Text] [Related]

  • 19. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J.
    Circ Res; 2006 Sep 01; 99(5):528-36. PubMed ID: 16902180
    [Abstract] [Full Text] [Related]

  • 20. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H.
    J Clin Invest; 1998 Feb 01; 101(3):527-35. PubMed ID: 9449684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.